Target intelligence / Profile preview

Myosin-XV (MYO15A)

Target
MYO15A
Molecular classification
Molecular motor protein, Actin-binding protein, Cytoskeletal protein, Enzyme (Motor ATPase activity)
01

Overview

Myosin-XV (MYO15A) is a very large unconventional myosin motor protein essential for the proper organization, elongation, and maintenance of actin-rich stereocilia in the inner ear hair cells, which are specialized organelles required for mechanotransduction—the process of converting sound vibrations into electrical signals for hearing. MYO15A has a unique, large N-terminal extension, an ATPase motor domain, IQ repeat domains, and a C-terminal tail containing specialized domains (MyTH4, FERM, SH3, PDZ ligand). It forms complexes with proteins such as whirlin and EPS8 to organize and stabilize the structure and function of stereocilia. Mutations in MYO15A cause DFNB3, a form of severe to profound autosomal recessive nonsyndromic deafness, by disrupting stereocilia assembly and/or maintenance. Mouse models and genetic studies in humans have extensively characterized both the gene and its functional consequences. MYO15A is not currently considered a direct drug target, but is a significant genetic biomarker for hereditary hearing loss[1][2][3].

Other names
Unconventional myosin-XVMYO15Unconventional myosin-15DFNB3Myosin 15Myosin XVa
02

Biological functions

Actin-based cellular motilityIntracellular traffickingOrganization and maintenance of stereocilia in cochlear hair cellsMechanotransduction (conversion of mechanical sound into neural signals in the ear)
03

Disease associations

Congenital autosomal recessive nonsyndromic deafness (DFNB3)Auditory system development disordersInner ear sensory cell maintenance disorders
04

Safety considerations

Gene therapy or interventions targeting MYO15A would require auditory system specificity, to avoid off-target impact on other actin/cytoskeleton processes
05

Biomarkers

MYO15A mutation (genetic marker for DFNB3 hearing loss)

Beyond the preview

Go deeper on Myosin-XV (MYO15A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Myosin-XV (MYO15A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call